Ukrain - A new cancer cure? A systematic review of randomised clinical trials

BMC Cancer

Volumn 5, Issue , 2005, Pages

  Ernst, Edzard ^a   Schmidt, Katja ^a  

^a UNIVERSITY OF EXETER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ASCORBIC ACID; CHELIDONINE; CHELIDONIUM EXTRACT; GEMCITABINE; NSC 631570; PLACEBO; UKRAIN; ALKALOID; BERBERINE DERIVATIVE; PHENANTHRIDINE DERIVATIVE; PLANT EXTRACT;

BLEEDING; BURNING SENSATION; CANCER; CLINICAL TRIAL; DATA ANALYSIS; DATA BASE; DRUG COST; FEVER; HUMAN; METHODOLOGY; REVIEW; SCORING SYSTEM; SYSTEMATIC REVIEW; TOXIC HEPATITIS; BLADDER TUMOR; BREAST TUMOR; CHELIDONIUM; CLINICAL TRIAL (TOPIC); COLORECTAL TUMOR; FACTUAL DATABASE; MEDICINAL PLANT; METABOLISM; MULTIMODALITY CANCER THERAPY; NEOPLASM; PANCREAS TUMOR; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICAL ANALYSIS; TREATMENT OUTCOME;

ALKALOIDS; ANTINEOPLASTIC AGENTS; BERBERINE ALKALOIDS; BREAST NEOPLASMS; CHELIDONIUM; CLINICAL TRIALS AS TOPIC; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; DATA INTERPRETATION, STATISTICAL; DATABASES, FACTUAL; HUMANS; NEOPLASMS; PANCREATIC NEOPLASMS; PHENANTHRIDINES; PLANT EXTRACTS; PLANTS, MEDICINAL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 25444461827     PISSN: 14712407     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-5-69     Document Type: Review

References (133)

1. Miller S: Ukrain. Bristol Cancer Help Centre 'handout' dated 05/03/2004 2004. (unpublished)
2. Nowicky J, Greif M, Hamler F, Hiesmayr W, Staub W: Biological activity of ukrain in vitro and in vivo. Chemioterapia 1987, 6:683-5.
3. Hohenwarter O, Strutzenberger K, Katinger H, Liepins A, Nowicky JW: Selective inhibition of in vitro cell growth by the antitumour drug Ukrain. Drugs Exp Clin Res 1992, 18:1-4.
4. Bruller W: Studies concerning the effect of Ukrain in vivo and in vitro. Drugs Exp Clin Res 1992, 18:13-6.
5. Slesak B, Nowicky JW, Harlozinska A: In vitro effects of Chelidonium majus L. alkaloid thiophosphoric acid conjugates (Ukrain) on the phenotype of normal human lymphocytes. Drugs Exp Clin Res 1992, 18:17-21.
6. Chlopkiewicz B, Marczewska J, Ejchart A, Anuszewska E, Koziorowska J: Evaluation of mutagenic, genotoxic and transofrming properties of Ukrain. Drugs Exp Clin Res 1992, 18:31-4.
7. Sotomayor EM, Rao K, Lopez DM, Liepins A: Enhancement of macrophage tumouricidal activity by the alkaloid derivative Ukrain. In vitro and in vivo studies. Drugs Exp Clin Res 1992, 18:5-11.
8. Staniszewski A, Slesak B, Kolodziej J, Harlozinska-Szmyrka A, Nowicky JW: Lymphocyte subsets in patients with lung cancer treated with thiophosphoric acid alkaloid derivatives from Chelidonium majus L. (Ukrain). Drugs Exp Clin Res 1992, 18:63-7.
9. Kleinrok Z, Jagiello-Wojtowicz E, Matuszek B, Chodkowska A: Basic central pharmacological properties of thiophosphoric acid alkaloid derivatives from Chelidonium majus L. Pol J Pharmacol Pharm 1992, 44:227-39.
10. Thakur ML, DeFulvio J, Tong J, John E, McDevitt MR, Damjanov I: Evaluation of biological response modifiers in the enhancement of tumor uptake of technetium-99 m labeled macromolecules. A preliminary report. J Immunol Methods 1992, 152:209-16.
11. Liepins A, Nowicky JW: Activation of spleen cell lytic activity by the alkaloid thiophosphoric acid derivative: Ukrain. Int J Immunopharmacol 1992, 14:1437-42.
12. Jodlowska-Jedrych B: Morphological studies on rat's liver after a ten-day treatment with Chelidonium majus L. alkaloid thiophosphoric acid derivative (Ukrain). Ann Univ Mariae Curie Sklodowska [Med] 1994, 49:119-24.
13. Liepins A, Nowicky JW, Bustamente JO, Lam E: Induction of bimodal programmed cell death in malignant cells by the derivative Ukrain (NSC-631570). Drugs Exp Clin Res 1996, 22:73-9.
14. Nowicky JW, Hiesmayr W, Nowicky W, Liepins A: Influence of Ukrain on DNA, RNA and protein synthesis in malignant cells. Drugs Exp Clin Res 1996, 22:81-91.
15. Nowicky JW, Hiesmayr W, Nowicky W, Liepins A: Influence of Ukrain on human xenografts in vitro. Drugs Exp Clin Res 1996, 22:93-7.
16. Jin JM, Nowicky JW, Liepins A: Mitogenic properties of Ukrain (NSC-6315170) on human peripheral blood monocytes: clinical implications. Drugs Exp Clin Res 1996, 22:99-101.
17. Liepins A, Nowicky JW: Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570). Drugs Exp Clin Res 1996, 22:103-13.
18. Susak YM, Kurik MV, Kravchenko OV, Zemskov SV: Certain biophysical properties of Ukrain. Drugs Exp Clin Res 1996, 22:185-7.
19. Zhalilo LI, Susak YM, Zemskov SV, Susak IA: Influence of Ukrain on the redox processes of hepatocytes. Drugs Exp Clin Res 1996, 22:189-91.
20. Brzosko WJ, Graczyk A, Konarski J, Nowicky JW: Synergic influence of Ukrain and photoporphyrin amino acid conjugates on human malignant cell lines. Drugs Exp Clin Res 1996, 22:193-4.
21. Ciebiada I, Korczak E, Nowicky JW, Denys A: Estimation of direct influence of Ukrain preparation on influenza viruses and the bacteria E. coli and S. aureus. Drugs Exp Clin Res 1996, 22:219-23.
22. Voltchek I, Kamyshentsev M, Lavinsky Y, Nowicky J, Medvedev Y, Litvinchuk L: Comparative study of the cytostatic effects of Oliphen and Ukrain. J Chemother 1996, 8:144-6.
23. Korolenko TA, Kaledin VI, Svechnikova IG, Li XV, Stashko JF, Ilnitskaya SI, et al.: Study of the antitumour effect of Ukrain: the role of macrpphage secretion of alpha-1-proteinase inhibitor. Drugs Exp Clin Res 1998, 24:271-6.
24. Kulik GI: Comparative in vitro study of the effects of the new antitumour drug Ukrain and several cytostatic agents on the thiol groups in the tissue of Guerin carcinoma and its resistance to cisplatin variant. Drugs Exp Clin Res 1998, 24:277-80.
25. Boyko VN, Belskiy SN: The influence of the novel drug Ukrain on hemo- and immunopoiesis at the time of its maximum radioprotective effect. Drugs Exp Clin Res 1998, 24:335-7.
26. TM, a semisynthetic Chelidonium majus alkaloid derivative, acts by inhibition of tubulin polymerization in normal and malignant cell lines. Cancer Lett 2000, 160:149-57.
27. Panzer A, Joubert AM, Eloff JN, Albrecht CF, Erasmus E, Seegers JC: Chemical analyses of Ukrain, a semi-synthetic Chelidonium majus alkaloid derivative, fail to confirm its trimeric structure. Cancer Lett 2000, 160:237-41.
28. Roublevskaia IN, Polevoda BV, Ludlow JW, Haake AR: Induced G2/M arrest and apoptosis in human epidermoid carcinoma cell lines by semisynthetic drug Ukrain. Anticancer Res 2000, 20:3163-7.
29. Panzer A, Joubert AM, Bianchi PC, Seegers JC: The antimitotic effects of Ukrain, a Chelidonium majus alkaloid derivative, are reversible in vitro. Cancer Lett 2000, 150:85-92.
30. Panzer A, Joubert AM, Bianchi PC, Hamel E, Seegers JC: The effects of chelidonine on tubulin polymerisation, cell cycle progression and selected signal transmission pathways. Eur J Cell Biol 2001, 80:111-8.
31. Roublevskaia IN, Haake AR, Ludlow JW, Polevoda BV: Induced apoptosis in human prostate cancer cell line LNCaP by Ukrain. Drugs Exp Clin Res 2000, 26:141-7.
32. Roublevskaia IN, Haake AR, Polevoda BV: Bcl-2 overexpression protects human keratinocyte cells from Ukrain-induced apoptosis but not from G2/M arrest. Drugs Exp Clin Res 2000, 26:149-56.
33. Voltchek I, Sologub T, Nowicky JW, Grigoryeva T, Belozyorova L, Belopolskaya M, et al.: Preliminary results of individual therapy of chronic hepatitis C by Ukrain and interferon-alpha. Drugs Exp Clin Res 2000, 26:261-6.
34. Votrin II, Voltchek IV, Kurochkin SN, Kolobkov SL: Effects of Ukrain on the activities of DNA-nicking enzymes. Drugs Exp Clin Res 2000, 26:267-73.
35. Jagiello-Wojtowicz E, Dudka J, Dawidek-Pietryka K: Effect of Ukrain on human liver alcohol dehydrogenase activity in vitro. Drugs Exp Clin Res 2000, 26:337-9.
36. Kuznetsova LP, Nikol'skaia EB, Sochilina EE, Faddeeva MD: The inhibition enzymatic hydrolysis of acetylthiocholine by acetylcholinesterase using principle alkaloids isolatted from celandine and macleya and their derivatives. Tsitologiia 2001, 43:1046-50.
37. Cordes N, Blaese MA, Plasswilm L, Rodemann HP, Van Beuningen D: Fibronectin and laminin increase resistance to ionizing radiation and the cytotoxic drug Ukrain in human tumour and normal cells in vitro. Int J Radiat Biol 2003, 79:709-20.
38. Kleinrok Z, Jagiello-Wojtowicz E, Nowicky JW, Chodkowska A, Feldo M, Matusek B: Some pharmacological properties of prolonged administration of Ukrain in rodents. Drugs Exp Clin Res 1992, 18:93-6.
39. Jagiello-Wojtowicz E, Kleinrok Z, Chodkowska A, Feldo M, Nowicky JW: Modification of antinociceptive action of morphine by Ukrain in rodents. Drugs Exp Clin Res 1992, 18:101-5.
40. Jagiello-Wojtowicz E, Kleinrok Z, Feldo M, Chodkowska A, Nowicky JW: Effect of Ukrain on the efficacy of anti-epileptic drugs against maximal electroshock-induced seizures in mice. Drugs Exp Clin Res 1992, 18:107-9.
41. Juszkiewicz T, Minta M, Wlodarczyk B, Biernacki B: Teratological evaluation of Ukrain in hamsters and rats. Drugs Exp Clin Res 1992, 18:23-9.
42. Wyczolkowska J, Czuwaj M, Maslinski C: The immunomodulating preparation Ukrain does not induce anaphylactic sensitization in mice and guinea pigs. Drugs Exp Clin Res 1992, 18:35-8.
43. Jagiello-Wojtowicz E, Kleinrok Z, Matuszek B, Surmaczynska B, Baran E, Nowicky W, et al.: Effect of three months treatment with Ukrain on peripheral blood morphology in rodents. Drugs Exp Clin Res 1992, 18:79-83.
44. Jagiello-Wojtowicz E, Kleinrok Z, Surmaczynska B, Baran E, Feldo M, Nowicky JW: Effect of single and three months treatment with Ukrain on aminotransferases (ALT and AST) and on the serum protein level in rodents. Drugs Exp Clin Res 1992, 18:85-7.
45. Jagiello-Wojtowicz E, Kleinrok Z, Nowicky JW, Matuszek B, Baran E, Surmaczynska B: Effect of single and prolonged administration of Ukrain on prolactin concentration in rats. Drugs Exp Clin Res 1992, 18:89-91.
46. Matysek M, Krolikowska-Prasal I, Jedrych B: Histological appreciation of the stomach after the application of thiophosphoric acid derivatives of Chelidonium majus L. (Ukrain) alkaloids. Ann Univ Mariae Curie Sklodowska 1992, 47:123-6.
47. Ciebiada I, Korczak E, Denys A, Nowicky JW: Effect of Ukrain preparation on immune response in mice affected by influenza virus. J Chemother 1995, 7:101-4.
48. Boyko VN, Voltchek IV, Petrov AS, Bubneov VP: Action of Ukrain, a cytostatic and immunomodulating drug, on effects of irradiation. Drugs Exp Clin Res 1996, 22:167-71.
49. Jagiello-Wojtowicz E, Kleinrok Z, Nowicky JW, Jablonski M, Gorzelak M, Chodkowska A, et al.: Effect of six-month treatment with Ukrain on early osteoporosis induced by ovariectomy in rats. Part I: Preliminary studies of bone parameters. Drugs Exp Clin Res 1996, 22:173-6.
50. Jagiello-Wojtowicz E, Kleinrok Z, Nowicky JW, Chodkowska A, Feldo M, Surmaczynska B, et al.: Effect of six-month treatment with Ukrain on early osteoporosis induced by ovariectomy in rats. Part II: Preliminary studies of peripheral blood parameters. Drugs Exp Clin Res 1996, 22:177-80.
51. Jagiello-Wojtowicz E, Kleinrok Z, Nowicky JW, Baran E: Effect of six-month treatment with Ukrain onearly osteoporosis induced by ovariectomy in rats. Part III: Preliminary studies of some hormone levels. Drugs Exp Clin Res 1996, 22:181-4.
52. Wyczolkowska J, Michon T, Nowicky JW: Inhibitory effect of thiophosphoric acid alkaloid derivatives from Chelidonium majus L. (Ukrain) on ovalbumin antigenicity and antiovalbumin IgE antibody response in mice. Drugs Exp Clin Res 1996, 22:195-200.
53. Jagiello-Wojtowicz E, Kleinrok Z, Chodkowska A, Nowicky JW, Piper H, Kubiatowski T: Antinociceptive effect of ten day administration of Ukrain in mice and interaction of the treatment with morphine. Drugs Exp Clin Res 1996, 22:201-3.
54. Jagiello-Wojtowicz E, Kleinrok Z, Nowicky JW, Chodkowska A, Kubiatowski T, Piper H: Interaction between Ukrain and morphine in their ten-day treatment in mice in the writhing syndrome test. Drugs Exp Clin Res 1996, 22:205-6.
55. Ciebiada I, Korczak E, Nowicky JW, Denys A: Does the Ukrain preparation protect mice against lethal doses of bacteria? Drugs Exp Clin Res 1996, 22:207-11.
56. Lozjuk RM, Lisnyak OI, Lozjuk LV: Theoretical grounds and experimental confirmation of the antiviral effect of the preparation Ukrain. Drugs Exp Clin Res 1996, 22:213-7.
57. Lisnyak OI, Lozjuk RM: Biological activity of some thiophosphoric derivatives of alkaloids with respect to influenza virus. Drugs Exp Clin Res 1996, 22:225-8.
58. Todor IN, Kazmin SD, Susak YaM, Zemskov SV: The influence of glucose, succinate, pH of the medium and higher temperature on the cytotoxic activity of the preparation Ukrain. Drugs Exp Clin Res 1998, 24:247-52.
59. Korolenko TA, Svechnikova IG, Filjushina EE, Kaledin VI, Vakulin GM, Usynin IF, et al.: Macrophage stimulation and antitumour effect of Ukrain. Drugs Exp Clin Res 1998, 24:253-60.
60. Svechnikova IG, Korolenko TA, Stashko JuF, Kaledin VI, Nikolin VP, Nowicky JW: The influence of Ukrain on the growth of HA-1 tumo rin mice: the role of cysteine proteinases as markers of tumor malignancy. Drugs Exp Clin Res 1998, 24:261-9.
61. Deneka ER: Morphometric and kinetic analysis of the growth of experimental sarcoma-45 in the presence of Ukrain. Drugs Exp Clin Res 1998, 24:281-5.
62. Kulik GI, Deneka ER, Todor IN, Karminozina LG: Study of acute toxicity of Ukrain in rats after intravenous injection. Drugs Exp Clin Res 1998, 24:287-93.
63. Jagiello-Wojtowicz E, Kleinrok Z, Feldo M, Chodkowska A, Szponar J, Urbanska EM: Six-week treatment with Ukrain in rabbits. Part I: Morphological parameters. Drugs Exp Clin Res 1998, 24:295-9.
64. Jagiello-Wojtowicz E, Kleinrok Z, Feldo M, Chodkowska A, Szklarczyk V, Urbanska EM: Six-week treatment with Ukrain in rabbits. Part II: Serum levels of gonadal hormones. Drugs Exp Clin Res 1998, 24:301-4.
65. Jagiello-Wojtowicz E, Kleinrok Z, Feldo M, Chodkowska A, Szklarczyk V, Urbanska EM: Six-week treatment with Ukrain in rabbits. Part III: Serum levels of thyroid hormones. Drugs Exp Clin Res 1998, 24:305-8.
66. Jagiello-Wojtowicz E, Kleinrok Z, Chodkowska A, Misztal G, Jagiello G: Preliminary pharmacokinetic studies of Ukrain in rats. Drugs Exp Clin Res 1998, 24:309-11.
67. Gorzelak M, Jablonski M, Patyra M, Jagiello-Wojtowicz E: Effect of intermittent three-month treatment with differnt doses of Ukrain on subregional femoral bone mineral density of sexually mature female rats. Drugs Exp Clin Res 1998, 24:313-6.
68. Jablonski M, Gorzelak M, Patyra M, Jagiello-Wojtowicz E: Effect of intermittent three-month treatment with different doses of Ukrain on subregional bone mineral density of the femur of ovariectomized rats. Drugs Exp Clin Res 1998, 24:317-20.
69. Jagiello-Wojtowicz E, Kleinrok Z, Chodkowska A, Szkodziak A, Siembida E, Gustaw K, et al.: Modification of antinociceptive action of Ukrain by endogenous nitric oxide in the writhing syndrome test in mice. Drugs Exp Clin Res 1998, 24:321-5.
70. Jagiello-Wojtowicz E, Kleinrok Z, Gustaw K: Interaction between Ukrain and Naltrexone in the writhing syndrome test in mice. Drugs Exp Clin Res 1998, 24:327-30.
71. Boyko VN, Zholus RB: A comparative evaluation of the influence of the complex drug Ukrain and its components on the effects of radiation. Drugs Exp Clin Res 1998, 24:331-3.
72. Boyko VN, Levshina YeV: A study of the influence of a novel drug Ukrain in vivo effects of low-dose ionizing radiation. Drugs Exp Clin Res 1998, 24:339-41.
73. Boyko VN, Zholus RB, Legeza VI: A study of the influence of different types of radioprotectors on the survival of mice treated with ionizing radiation over a wide dose range. Drugs Exp Clin Res 1998, 24:343-7.
74. Hruby R: Ukrain: acute toxicity after intravenous, intramuscular and oral administration in rats. Drugs Exp Clin Res 2000, 26:157-61.
75. Doroshenko YM, Karavay AV, Hodysch YY, Uglyanitsa KN, Nowicky JW, Nefyodov LI: The dynamics of concentration of the main fluorescent component of Ukrain in the tissues and blood plasma of rats with W-256 tumor after a single intravenous injection. Drugs Exp Clin Res 2000, 26:171-7.
76. Kurochkin SN, Kolobkov SL, Votrin II, Voltchek IV: Induction of apoptosis in cultured Chinese hamster ovary cells by Ukrain and its synergistic action with etoposide. Drugs Exp Clin Res 2000, 26:275-8.
77. Korolenko TA, Djanayeva SJ, Falameyeva OV, Wevers RA, Filjushina EE, Buzueva II, et al.: Chitotriosidase as a new marker of macrophage stimulation in a tumor model treated with cyclophosphamide and Ukrain. Drugs Exp Clin Res 2000, 26:279-83.
78. Korolenko TA, Poteryaeva ON, Djanayeva SJ, Svechnikova IG, Kaleidn VI, Timofeyeva OA, et al.: Cystatin C in LS lymphosarcoma and HA-1 hepatoma treated with Ukrain and cyclophosphamide and involvement of apoptosis. Drugs Exp Clin Res 2000, 26:285-92.
79. Djanayeva SJ, Korolenko TA, Svechnikova IG, Falameyeva OV, Korolenko E, Kaledin VI, et al.: Influence of Ukrain and cyclophosphamide administration on HA-1 murine hepatoma and LS lymphoma on aspartic proteinase cathepsin D. Drugs Exp Clin Res 2000, 26:293-9.
80. Poteryaeva ON, Falameyeva OV, Korolenko TA, Kaledin VI, Djanayeva SJ, Nowicky JW, et al.: Cysteine proteinase inhibitor level in tumor and normal tissues in control and cured mice. Drugs Exp Clin Res 2000, 26:301-6.
81. Luksa-Lichtenthaler GL, Ladutko EI, Nowicky JW: Influence of Ukrain on the nuclear thyroid hormone receptors after short-term gamma-irradiation. Drugs Exp Clin Res 2000, 26:307-10.
82. Luksa-Lichtenthaler GL, Ladutko EI, Nowicky JW: Radiomodification effects of Ukrain, a cytostatic and immunomodulating drug, on intracellular glucocorticoid reception during short-term gamma-irradiation. Drugs Exp Clin Res 2000, 26:311-5.
83. Jablonski M, Korczak W, Gorzelak M, Jagiell-Wojtowicz E: Intermittent three-month treatment with Ukrain in intact and ovariectomized rats. Part III: Effect on the nativ eelectron paramagnetic resonance signal intensity of the femur. Drugs Exp Clin Res 2000, 26:333-6.
84. Stabuc B, Benedicic D: Ukrain with chemotherapy in malignant melanoma (case report). Drugs Exp Clin Res 1996, 22:231-3.
85. Hamler F, Hiesmayr W, Korsh O, Melnyk A: Ukrain monotherapy in malignant melanoma (case report). Drugs Exp Clin Res 1996, 22:235-7.
86. Kotsay B, Lisnyak O, Myndiuk O, Romanys-hyn J, Fabri O: Ukrain treatment of rhabdomyosarcoma (case report). Drugs Exp Clin Res 1996, 22:239-41.
87. Kadan P, Korsh OB, Melnyk A: Ukrain therapy of recurrent breast cancer with lung metastases (case report). Drugs Exp Clin Res 1996, 22:243-5.
88. Schramm E, Nowicky JW, Godysh Y: Biophysiological effects of Ukrain therapy in a patient with breast cancer (case report). Drugs Exp Clin Res 1996, 22:247-54.
89. Kroiss T, Melnyk A, Korsh OB: Ukrain treatment in carcinoma of the cervix (case report). Drugs Exp Clin Res 1996, 22:255-7.
90. Lohninger A, Korsh OB, Melnyk A: Combined therapy with Ukrain and chemotherapy in ovarian cancer (case report). Drugs Exp Clin Res 1996, 22:259-62.
91. Sakalo VS, Korsh OB, Melnyk A: Ukrain treatment in a patient with non-seminomatous germ-cell tumour of testis (case report). Drugs Exp Clin Res 1996, 22:263-5.
92. Vyas JJ, Jain VK: Ukrain treatment in carcinoma of the oesophagus (case report). Drugs Exp Clin Res 1996, 22:267-9.
93. Kadan P, Korsh OB, Hiesmayr W: Ukrain in the treatment of urethral recurrent carcinoma (case report). Drugs Exp Clin Res 1996, 22:271-3.
94. Steinacker J, Kroiss T, Korsh OB, Melnyk A: Ukrain therapy in a frontal anaplastic grade III astrocytoma (case report). Drugs Exp Clin Res 1996, 22:275-7.
95. Steinacker J, Korsh OB, Melnyk A: Ukrain therapy of a recurrent astrocytoma of the optic nerve (case report). Drugs Exp Clin Res 1996, 22:279-81.
96. Voltchek IV, Liepins A, Nowicky JW, Brzosko WJ: Potential therapeutic efficacy of Ukrain (NSC 631570) in AIDS patients with Kaposi's sarcoma. Drugs Exp Clin Res 1996, 22:283-6.
97. Aschhoff B: Ukrain treatment in a patient with stage IV neuroblastoma. A case report. Drugs Exp Clin Res 1998, 24:243-5.
98. Nowicky JW, Staniszewski A, Zbroja-Sontag W, Slesak B, Nowicky W, Hiesmayr W: Evaluation of thiophosphoric acid alkaloid derivatives from Chelidonium majus L. ("Ukrain") as an immunostimulant in patients with various carcinomas. Drugs Exp Clin Res 1991, 17:139-43.
99. Danysz A, Kokoschinegg M, Hamler F: Clinical studies of Ukrain in healthy volunteers (phase 1). Drugs Exp Clin Res 1992, 18:39-43.
100. Musianowycz J, Judmajer F, Manfreda D, Spangler P, Albrecht H, Hoffmann J, et al.: Clinical studies of Ukrain in terminal cancer patients (phase II). Drugs Exp Clin Res 1992, 18:45-50.
101. Nowicky JW, Manolakis G, Meijer D, Vatanasapt V, Brzosko WJ: Ukrain both as an anti cancer and immunoregulatory agent. Drugs Exp Clin Res 1992, 18:51-4.
102. Danilos J, Zbroja-Sontag W, Baran E, Kurylcio L, Kondratowicz L, Jusiak L: Preliminary studies on the effect of Ukrain (Tris(2- ([5bS-(5ba, 6b, 12ba)]-5b, 6, 7, 12b, 13, 14-hexahydro-13- methyl[1, 3] benzodioxolo [5, 6-v]-1-3-dioxolo [4, 5-i] phenanthridinium-6-o1]-Ethaneaminyl) Phosphinesulfide.6HCl) on the immunological response in patients with malignant tumours. Drugs Exp Clin Res 1992, 18:55-62.
103. Pengsaa P, Wongpratoom W, Vatanasapt V, Udomthavornsuk B, Mairieng E, Tangvorapongchai V, et al.: The effects of thiophosphoric acid (Ukrain) on cervical cancer, stage IB bulky. Drugs Exp Clin Res 1992, 18:69-72.
104. Lohninger A, Hamler F: Chelidonium majus L. (Ukrain) in the treatment of cancer patients. Drugs Exp Clin Res 1992, 18:73-7.
105. Brzosko WJ, Uglyanica KN, Fomin KA, Nowicky JW: Influence of Ukrain on breast cancer. Drugs Exp Clin Res 1996, 22:127-33.
106. Zemskov SV, Iaremchuk OIa, Susak IaM, Deneka IeR, Kravchenko OV, Iatsyk IM: The initial experience of usig the preparation Ukrain in treating cancer patients in Ukraine. Lik Sprava 1996, Jan-Feb:158-61.
107. Nefyodov LI, Uglyanitsa KN, Smirnov VY, Karavay AV, Brzosko WJ: Comparative evaluation of blood plasma and tumor tissue amino acid pool in radiation or neoadjuvant preoperative therapies of breast cancer with the antitumour drug Ukrain. Drugs Exp Clin Res 2000, 26:231-7.
108. Uglyanitsa KN, Nefyodov LI, Karayedova LM, Nowicky JW, Brzosko WJ: Clinical aspects of cancer treatment and new biochemical mechanisms of the drug Ukrain. Drugs Exp Clin Res 2000, 26:239-47.
109. Nefyodov LI, Uglyanica KN, Smirnov VY, Doroshenko YM, Fomin KA, Nowicky JW, et al.: Amino acids and their derivatives in tumour tissue from patients with breast cancer treated with Ukrain. Part VI. Drugs Exp Clin Res 1996, 22:159-61.
110. Nefyodov LI, Uglyanica KN, Smirnov VY, Doroshenko YM, Fomin KA, Nowicky JW, et al.: Amino acids and their derivatives in blood plasma of patients with breast cancer treated with Ukrain. Part V. Drugs Exp Clin Res 1996, 22:155-7.
111. Uglyanica KN, Maciuk JR, Fomin KA, Nefyodov LI, Kravchuk RI, Vinogradova LM, et al.: Influence of Ukrain on patients with surgucally treated breast cancer. Part IV. Drugs Exp Clin Res 1996, 22:147-53.
112. Fomin KA, Uglyanica KN, Nefyodov LI, Djurd TI, Nowicky JW, Brzosko WJ, et al.: Influence of Ukrain on patients with surgically treated breast cancer. Part III. The immune system. Drugs Exp Clin Res 1996, 22:143-5.
113. Uglyanica KN, Fomin KA, Nefyodov LI, Vilkiewich TW, Nowicky JW, Brzosko WJ, et al.: Influence of Ukrain on patients with surgically treated breast cancer. Part II. Hormonal profile. Drugs Exp Clin Res 1996, 22:139-43.
114. Uglyanica KN, Fomin KA, Nefyodov LI, Nowicky JW, Brzosko WJ, Jankowski A: Influence of Ukrain on patients with surgically treated breast cancer. Part I. Clinical and laboratory parameters. Drugs Exp Clin Res 1996, 22:135-8.
115. Nefyodov LI, Uglyanitsa KN, Nechiporenko NA, Smirnov VY, Brzosko WJ, Karavay NL: New biochemical mechanisms of the anticancer effect of Ukrain in the treatment of cancer of the urinary bladder. Drugs Exp Clin Res 2000, 26:195-9.
116. Uglyanitsa KN, Nechiporenko NA, Nefyodov LI, Brzosko WJ: Ukrain therapy of stage T1NOMO bladder cancer patients. Drugs Exp Clin Res 1998, 24:227-30.
117. Uglyanica KN, Fomin KA, Nefyodov LI, Nowicky JW, Brzosko WJ, Jankowski A: Influence of Ukrain on patients with surgically treated breast cancer (introductory remarks). Drugs Exp Clin Res 1996, 22:123-5.
118. Uglyanitsa KN, Nefyodov LI, Doroshenko YM, Brzosko WJ: Comparison of the efficacy of different doses of Ukrain in the combined treatment of breast cancer. Drugs Exp Clin Res 2000, 26:201-21.
119. Jadad AR, Moore A, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, et al.: Assessing the quality of reports of randomized clinical trials: Is blinding necessary. Controlled Clin Trials 1996, 17:1-12.
120. Susak YM, Zemskov SV, Yaremchuk OY, Kravchenko OV, Yatsyk IM, Korsh OB: Comparison of chemotherapy and X-ray therapy with Ukrain monotherapy for colorectal cancer. Drugs Exp Clin Res 1996, 22:115-22.
121. Bondar GV, Borota AV, Yakovets YI, Zolotukhin SE: Comparative evaluation of the complex treatment of rectal cancer patients (chemotherapy and X-ray therapy, Ukrain monotherapy). Drugs Exp Clin Res 1998, 24:221-6.
122. Zemskov VS, Procopchuk OL, Susak YM, Zemskov SV, Hodysh YY, Zemskova MV: Ukrain (NSC-631570) in the treatment of pancreas cancer. Drugs Exp Clin Res 2000, 26:179-90.
123. Uglyanitsa KN, Nefyodov LI, Brzosko WJ: Comparative evaluation of the efficiency of various Ukrain doses in the combined treatment of breast cancer. Report I. Clinical aspects of Ukrain application. Drugs Exp Clin Res 2000, 26:223-30.
124. Zemskov SV, Prokopchuk O, Susak Y, Zemskov S, Tkachenko O, Hodysh Y, et al.: Efficacy of Ukrain in the treatment of pancreatic cancer. Langenbecks Arch Surg 2002, 387:84-9.
125. Gansauge F, Ramadani M, Pressmar J, Gansauge S, Muehling B, Stecker K, et al.: NSC-631570 (Ukrain) in the palliative treatment of pancreatic cancer. Results of a phase II trial. Langenbecks Arch Surg 2002, 386:570-4.
126. Susak YM, Yaremchuk OY, Zemskov VS, Kravchenko OB, Liepins A, Yatsyk IM, et al.: Randomised clinical study of Ukrain on colorectal cancer. Eur J Cancer 1995, 31:S153. Abstract 733.
127. Anon: Phase II Studie zur Behandlung des fortgeschrittenen, inoperablen Pankreaskarzinoms mit Ukrain. Der Arzneimittelbrief 2002, 36:39.
128. Jellin JM, Gregory P, Batz F, Hitchens K, et al.: Pharmacist's Letter/Prescriber's Letter Natural Medicines Comprehensive Database. 3rd edition. Stockton, CA: Therapeutic Research Faculty; 2000.
129. Benninger J, Schneider HT, Schuppan D, Kirchner T, Hahn EG: Acute hepatitis induced by Greater Celandine (Chelidonium majus). Gastroenterol 1999, 117:1234-7.
130. Jagiello-Wojtowicz E, Kleinrok Z, Urbanska EM: Ukrain (NSC-631570) in experimental and clinical studies: a review. Drugs Exp Clin Res 1998, 24:213-9.
131. Bone K: Adverse reaction reports: hepatitis induced by greater celandine. Phytother 2000, 5:11-6.
132. Crijus APG, De Smet PAGM, van den Heuvel M, Schot BW, Haagsma EB: Acute hepatitis after use of herbal preparation with greater celandine. Ned Tijdschr Geneeskd 2002, 146:124-8.
133. Hopf G: Ukrain® - Fortschritt oder Rückschritt in der medikamentösen Therapie onkologischer Erkrankungen? Deutsche Zeitschrift für Onkologie 2002, 34:31-6.